Clinical Trial Update: Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and acceptability of two sequential psilocybin doses in Bipolar Disorder Type II with depression and suicidality; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Bipolar Disorder Type Ii
• Suicidal Ideation

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Bipolar II Disorder, Depression, Bipolar | Phase 2 | Status: RECRUITING